Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Breast Neoplasms 944Neoplasms 713Prostatic Neoplasms 498Lung Neoplasms 402Colorectal Neoplasms 363Carcinoma, Non-Small-Cell Lung 362Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 239Brain Neoplasms 230Neoplasm Metastasis 225Multiple Myeloma 218Carcinoma, Hepatocellular 202Head and Neck Neoplasms 187Glioblastoma 183Precursor Cell Lymphoblastic Leukemia-Lymphoma 181Melanoma 177Ovarian Neoplasms 170Squamous Cell Carcinoma of Head and Neck 161Rectal Neoplasms 145Uterine Cervical Neoplasms 144Recurrence 143Hematologic Neoplasms 137Sarcoma 136Glioma 132Stomach Neoplasms 129Triple Negative Breast Neoplasms 127Carcinoma, Renal Cell 126Myelodysplastic Syndromes 114Colonic Neoplasms 113Esophageal Neoplasms 111

Interventions

selinexor 1pazopanib 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Histiocytoma, Angiomatoid Fibrous × 90 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡